SAN CLEMENTE, Calif., March 16, 2017 -- CareTrust REIT, Inc. (NASDAQ:CTRE) today announced that its Board of Directors has declared a quarterly common stock cash dividend of $0.185 per share, payable on April 14, 2017 to common stockholders of record as of the close of business on March 31, 2017.
Chief Financial Officer Bill Wagner noted that the $0.185 per share quarterly dividend represents a 8.8% increase over the prior quarterly dividend, and a FFO payout ratio of approximately 66% based on the midpoint of the company’s 2017 normalized FFO guidance, compared to 62% for 2016. “CareTrust REIT grew both its asset base and ongoing funds from operations significantly in 2016, and has continued that growth trajectory in 2017 to date,” said Mr. Wagner. “So even with the increase, our dividend remains among the best-protected of all our industry peers,” he added.
Greg Stapley, Chairman and Chief Executive Officer, added that CareTrust REIT has an active acquisition pipeline, providing ample opportunity to use the retained FFO to create additional shareholder value. “We continue to believe that our dividend policy strikes a smart balance between conserving capital for growth while providing shareholders with an attractive dividend yield," he said.
About CareTrust REITTM
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 158 net-leased healthcare properties and three operated seniors housing properties in 21 states, CareTrust REIT is pursuing opportunities nationwide to acquire additional properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses. More information about CareTrust REIT is available at www.caretrustreit.com.
Contact: CareTrust REIT, Inc. (949) 542-3130 [email protected]


Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 



